Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Chemotherapy, Surgery and Radiotherapy for Ewing's Sarcoma (GEIS-21)
NCT01696669Phase 2Completed
- Sponsor
- Spanish Group for Research on Sarcoma
- Start
- Mar 2010
- Primary completion
- Dec 2017
- Modality
- Monoclonal Antibodies, Targeted Liposomes, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of vincristine sulfate liposome injection, pegylated liposomal doxorubicin, cyclophosphamide, ifosfamide, etoposide in Ewing sarcoma, sponsored by Spanish Group for Research on Sarcoma. Started Mar 2010; status: completed.
02
Drugs
vincristine sulfate liposome injectionpegylated liposomal doxorubicincyclophosphamideifosfamideetoposide
03
Conditions
Ewing sarcoma
Beyond the preview
Go deeper on NCT01696669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01696669.